Skip to main content
Article thumbnail
Location of Repository

Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets

By T Hilton Grayson, Stephen J Ohms, Therese D Brackenbury, Kate R Meaney, Kaiman Peng, Yvonne E Pittelkow, Susan R Wilson, Shaun L Sandow and Caryl E Hill
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2006). [Mechanisms of hypertension in the central nervous system]. Yakugaku Zasshi
  2. (2005). A physiogenomic approach to study the regulation of blood pressure. Physiol Genomics
  3. (2001). A: Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res
  4. (2003). A: Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res
  5. (1982). and junctions of rat aortic endothelium during experimental hypertension: a morphometric and freeze fracture study. Lab Invest
  6. (2005). Auffray C: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res
  7. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol
  8. (2005). Blockade of angiotensin II provides additional benefits in hypertension- and ageingrelated cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
  9. (2005). C: Animal models of hypertension: an overview.
  10. (2005). CE: Angiotensin-converting enzyme inhibition restores endothelial but not medial connexin expression in hypertensive rats.
  11. (2004). CE: Attenuation of conducted vasodilatation in rat mesenteric arteries during hypertension: role of inwardly rectifying potassium channels.
  12. (2002). CE: Connexin37 is the major connexin expressed in the media of caudal artery. Arterioscler Thromb Vasc Biol
  13. (2002). CE: Decreased endothelial size and connexin expression in rat caudal arteries during hypertension.
  14. (2004). CE: Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery.
  15. (2003). CE: Structure, function, and endothelium-derived hyperpolarizing factor in the caudal artery of the SHR and WKY rat. Arterioscler Thromb Vasc Biol
  16. (2001). Dedicated myosin light chain kinases with diverse cellular functions.
  17. (1987). Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man.
  18. Expression Omnibus
  19. (2002). Fabsitz RR, Roman MJ: Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol
  20. for Biotechnology Information [ h t t p : /
  21. (2005). Halfon MS: Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol
  22. (2005). Heagerty AM: Small artery structure and hypertension: adaptive changes and target organ damage.
  23. Human Protein Reference Database []
  24. (2003). Hunt SC: Genetics of hypertension. Genet Med
  25. (2007). Insel PA: Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. Faseb J
  26. (2005). Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol
  27. (2000). JA: The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat.
  28. (1997). JC: Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension
  29. (2003). KJ: Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice.
  30. (2005). KJ: RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol
  31. (2001). Kurzchalia TV: Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science
  32. (2003). Mittmann C: Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther
  33. (2003). MP: The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv
  34. (2001). Mulvany MJ: Location of resistance arteries.
  35. (2004). Nadaud S: Profiling of aortic smooth muscle cell gene expression in response to chronic inhibition of nitric oxide synthase in rats. Circulation
  36. (2003). Open source software for the analysis of microarray data. Biotechniques
  37. (2002). Parkington HC: Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res
  38. (2004). Quinapril effects on resistance artery structure and function in hypertension. Naunyn Schmiedebergs Arch Pharmacol
  39. (2003). Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med
  40. (2005). Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood
  41. (2004). RL: Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque. J Vasc Surg
  42. (1999). Schiffrin EL: Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation
  43. (2005). Schyvens CG, Whitworth JA: Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
  44. (2005). Semplicini A: Angiotensin II-induced over-activation of p47phox in fibroblasts from hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II? J Hypertens
  45. (2000). SM: A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res
  46. (2005). Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol
  47. (2003). SR: Visualisation of gene expression data - the GE-biplot, the Chip-plot and the Gene-plot. Stat Appl Genet Mol Biol
  48. (2004). Statistics for Microarrays: Design, Analysis and Inference.
  49. (1990). Structural and functional alterations of mesenteric vascular beds in spontaneously hypertensive rats. Jpn Heart J
  50. (2005). Structural and genetic bases of arterial stiffness. Hypertension
  51. (2005). Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system.
  52. (2002). The nitric oxide system in glucocorticoid-induced hypertension.
  53. (2000). The p38 signal transduction pathway: activation and function. Cell Signal
  54. (2004). Touyz RM: From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.
  55. (2003). Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension
  56. (2004). WC: Caveolae and caveolins in the cardiovascular system. Circ Res

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.